/PRNewswire/ —The Board of Directors of Behavioral Health Group (“BHG” or “the Company”) today announced the appointment of Kelly J. Clark, MD, MBA, as Chief Medical Officer. Dr. Clark joined BHG July 9, 2012.
Dr. Clark joins BHG with a wide breadth and depth of both clinical and administrative experience. She has practiced addiction medicine and psychiatry throughout the continuum of care, and taught addiction treatment as a faculty member of the University of Massachusetts. She comes to BHG having most recently worked to integrate medical and behavioral health care management as Medical Director at CDPHP. She serves as President of the Kentucky Society of Addiction Medicine, where she has practiced medicine for several years and served as Medical Director of a number of Opioid Treatment Programs.
“I am thrilled to join BHG in the work of providing excellent treatment services to those patients suffering under the epidemic of opioid addiction,” said Clark. “This disease is ravaging individual lives and entire communities across the country. BHG is uniquely situated to bring best practice medication assisted treatment to thousands of patients, and I am excited to work to increase access to evidence-based, physician-directed, team-delivered, high-quality care”.
A Phi Beta Kappa graduate of Coe College in Cedar Rapids, Iowa, Kelly holds a Doctor of Medicine degree from the University of Wisconsin, and a Master of Business Administration with Additional Certification in Health Sector Management from the Fuqua School of Business at Duke University. She is currently on the faculty of the Virginia Tech Carillion School of Medicine. Dr. Clark is a Fellow of the American Society of Addiction Medicine, where she serves as a Director, and is a Distinguished Fellow of the American Psychiatric Association.
BHG’s Chairman and CEO, Michael N. Cannizzaro, said of the appointment: “The Board is delighted to welcome Kelly to BHG’s executive team as Chief Medical Officer. Her talents and experiences will be invaluable in directing the pharmacotherapy and behavioral therapy aspect of our business as she builds the Medical Directorate of our company.”
Behavioral Health Group (BHG) is a fast-growing healthcare company creating a new class of recovery center for individuals with substance use disorder (SUD). BHG specializes in medication-assisted recovery (MAR) combined with addiction counseling delivered through the largest network of Joint Commission-accredited outpatient treatment and recovery centers in the U.S. Founded in 2006 and led by an experienced executive team with deep experience in the healthcare and behavioral health industries, BHG believes that comprehensive, evidence-based, personalized treatment plans focused on real recovery restore lives, strengthen families, and rejuvenate the communities in which we serve. BHG capabilities include a full range of counseling and behavioral health therapies for individual, family, and group counseling, medication-assisted recovery, intensive outpatient programs, mental health services, case management, and community resource coordination services delivered in its treatment centers and through telehealth. BHG treatment centers provide access to all FDA-approved medications through in-center dosing or prescriptions programs. BHG accepts Medicare, Medicaid, most major commercial health plans, and works with state grants to support patients who choose to self-pay. With 117 locations in 24 states, BHG has more than 2,100 employees who serve more than 43,000 patients. To learn more, visit bhgrecovery.com.